Evaluation of the discrepant Mycobacterium tuberculosis strains between any ordinary susceptibility testing and rpoB gene analysis by the line probe assay

Kekkaku

Volumn 83, Issue 8, 2008, Pages 577-583

  Yoshida, Shiomi ^a   Suzuki, Katsuhiro ^a   Tsuyuguchi, Kazunari ^a   Tomita, Motohisa ^b   Okada, Masaji ^a   Sakatani, Mitsunori ^a  

^a NATIONAL HOSPITAL ORGANIZATION KINKI CHUO CHEST MEDICAL CENTER   (Japan)

^b Department of Clinical Laboratory ^*

Author keywords

Drug susceptibility testing; M. tuberculosis; MIC; Resistance conferring mutation; rpoB

Indexed keywords

BACTERIAL PROTEIN; RIFAMPICIN; RPOB PROTEIN, MYCOBACTERIUM TUBERCULOSIS;

ARTICLE; DRUG EFFECT; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MYCOBACTERIUM TUBERCULOSIS;

BACTERIAL PROTEINS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; RIFAMPIN;

EID: 54449094170     PISSN: 00229776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Hillemann D, Weizenegger M, Kubica T, et al. : Use of the genotype MDRDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates. J Clin Microbiol. 2005; 43: 3699-3703.
2. Lin SYG, Probert W, Lo M, et al. : Rapid detection of iso- niazid and rifampin resistance mutations in Mycobacterium tuberculosis complex from cultures or smear-positive sputa by use of molecular beacons. J Clin Microbiol. 2004; 42 : 4204-4208.
3. Hirano K, Abe C, Takahashi M : Mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis strains isolated mostly in Asian countries and their rapid detection by line probe assay. J Clin Microbiol. 1999; 37: 2663-2666.
4. van Embden JDA, Cave MD, Crawford JT, et al. : Strain identification of Mycobacterium tuberculosis by DNA fingerprinting : recommendations for a standardized methodology. J Clin Microbiol. 1993; 31: 406-409.
5. Zhang Y, Heym B, Allen B, et al. : The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature. 1992; 358: 591.-593.
6. 9WilliamsDL,WaguespackC,EisenachK,etal.:Character- izationofrifampinresistanceinpathogenicmycobacteria.AntimicrobAgentsChemother. 1994;38:2380-2386.(Pubitemid24304234)
7. Ohno H, Koga H, Kohno S, et al.: Relationship between rifampin MICs for and rpoB mutations of Mycobacterium tuberculosis strains isolated in Japan. Antimicrob Agents Chemother. 1996; 40: 1053-1056.
8. Scorpio A, Zhang Y : Mutations in pncA, a gene encoding pyrazinamidase / nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus. Nat Med. 1996; 2: 662-667.
9. 12SreevatsanS,StockbauerKE,PanX,etal.: EthambutolresistanceinMycobacteriumtuberculosis:criticalroleofembBmutations. AntimicrobAgentsChemother.1997;41:1677-1681.(Pubitemid27339866)
10. Telenti A, Imboden P, Marchesi F, et al. : Detection of rifampicin-resistant mutations in Mycobacterium tuberculosis. Lancet. 1993; 341: 647-650.
11. Abe C, Hirano K, Wada M, et al. : Resistance of Mycobacterium tuberculosis to four first-line anti-tuberculosis drugs in Japan, 1997. Int J Tuberc Lung Dis. 2001; 5: 46-52.
12. American Thoracic Society: Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med. 2000; 161: 1376-1395.
13. Rossau. R, Traore H, de Beenhouwer H, et al. : Evaluation of the INNO-LiPA Rif. TB assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampin. Antimicrob Agents Chemother. 1997; 41: 2093-2098.
14. Gagneux S, Long CD, Small PM, et al.: The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science. 2006; 312: 1944-1946.
15. Cavusoglu C, Hilmioglu S, Guneri. S, et al. : Characterization of rpoB mutations in rifampin-resistant clinical isolates of Mycobacterium tuberculosis from Turkey by DNA sequencing and line probe assay. J Clin Microbiol. 2002; 40: 4435-4438.
16. Hwang HY, Chang CY, Chang LL, et al. : Characterization of rifampicin-resistant Mycobacterium tuberculosis in Taiwan. J Med Microbiol. 2003; 52: 239-245.
17. Valim ARM, Rossetti MLR, Ribeiro MO, et al. : Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis isolates from Brazil. J Clin Microbiol. 2000; 38:3119-3122.
18. Matsiota-Bernard P, Vrioni G, Marinis E: Characterization of rpoB mutations in rifampin-resistant clinical Mycobacterium tuberculosis isolates from Greece. J Clin Microbiol. 1998; 36: 20-23.
19. Morlock GP, Plikaytis BB, Crawford JT: Characterization of spontaneous, in vitro-selected, rifampin-resistant mutants of Mycobacterium tuberculosis strains H37Rv. Antimicrob Agents Chemother. 2000; 44: 3298-3301.
20. Small PM, Shafer RW, Hopewell PC, et al. : Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection. N Engl J Med. 1993; 328:1137-1144.
21. Watterson SA, Wilson SM, Yates MD, et al. : Comparison of three molecular assays for rapid detection of rifampin resistance in Mycobacterium tuberculosis. J Clin Microbiol. 1998; 36: 1969-1973.
22. Heym B, Honore N, Truffot-Pernot C, et al. : Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis : a molecular study. Lancet. 1994; 344:273-278. (Pubitemid 24230296)
23. Tuberculosis Research Committee (Ryoken) : Drug-resistant Mycobacterium tuberculosis in Japan : a nationwide survey, 2002. Int J Tuberc Lung Dis. 2007; 11: 1129-1135.
24. Narvskaya O, Often T, Limeschenko E, et al. : Nosocomial, outbreak of multidrug-resistant tuberculosis caused by a strain of Mycobacterium tuberculosis W-Beijing family in St. Petersburg, Russia. Eur J Clin Microbiol Infect Dis. 2002; 21: 596-602.
25. CamineroJA,PenaMJ,Campos-HerreroMI,etal.: ExogenousreinfectionwithtuberculosisonaEuropeanislandwithamoderateincidenceof disease.AmJRespirCritCareMed.2001;163:717-720.(Pubitemid32230835)
26. Bandera A, Gori A, Catozzi L, et al. : Molecular epidemiology study of exogenous reinfection in an area with a low incidence of tuberculosis. J Clin Microbiol. 2001 ; 39 : 2213-2218. (Pubitemid 32531483)